Parenteral Drugs (India) Ltd

524689

Summary

Fair Value Assessment
Fair Value Not Available.
Fair ValueQUncertainty
Close Price3.39Mar 11, 2025
Request timeout.
Previous Close
3.39
Day Range
Year Range
Bid / Ask
Market Cap
Volume / Average
Beta (5-Year)
-0.10
Shares Outstanding
29.82 Mil
Primary Exchange

Business Description
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
Contact
Navlakha Crossing, A. B. Road Shree Ganesh Chambers, Indore, MP 452001
T +91 7316652001
www.pdindia.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2022
Fiscal Year End
Mar 31, 2022
Employees
909

Key Metrics

Income Statement (in Mil, except ratios)
03/31/2022
03/2021
03/2020
03/2019
03/2018
03/2017
Revenue
84.96 121.53 240.25 319.98 2,168.05 2,297.18
Revenue Growth %
-30.17% -49.42% -24.92% -85.84% -9.22% -7.11%
Gross Profit
30.31 48.37 13.40 75.64 370.93 519.82
Gross Profit Margin %
35.67% 39.80% 5.58% 23.64% 17.11% 22.63%
Operating Income
-551.62 -290.49 -315.88 -867.78 -425.13 -268.09
Operating Margin %
-649.25% -239.04% -131.48% -271.20% -19.61% -11.67%
EBIT
-28.79 -291.00 -318.64 -854.55 -456.75 -413.34
EBIT Margin %
-33.89% -239.46% -132.63% -267.06% -21.07% -17.99%
EBITDA
372.69 -117.73 -145.18 -163.36 -214.32 -164.49
EBITDA Margin %
438.65% -96.88% -60.43% -51.05% -9.89% -7.16%
Net Income
-763.62 -1,217.13 -1,140.73 -1,479.07 -1,189.42 -1,152.04
Net Profit Margin %
-898.77% -1,001.55% -474.81% -462.23% -54.86% -50.15%
Basic EPS
-25.61 -40.82 -38.26 -49.61 -39.89 -38.64
Diluted EPS
-25.61 -40.82 -38.26 -49.61 -39.89 -38.64
Normalized EPS
Total Dividends per Share
Balance Sheet (in Bil, except ratios)
09/30/2021
03/2021
03/2020
03/2019
03/2018
03/2017
Total Assets
5.77 5.68 5.52 5.41 8.90 10.19
Total Liabilities
13.26 12.51 11.13 9.87 10.27 8.08
Total Debt
1.07 10.72 9.46 8.40 8.25 6.49
Total Equity
-7.48 -6.83 -5.61 -4.47 -1.36 2.11
Cash And Cash Equivalents
Working Capital
-11.51 -10.76 -9.38 -8.10 -4.94 -2.97
Shares Outstanding (Mil)
0.03 0.03 0.03
Book Value Per Share
-276.37 -229.03 -188.25 -149.89 -45.76 64.52
Total Debt To Equity
3.08
Cash Flow Statement (in Mil, except ratios)
03/31/2022
03/2021
03/2020
03/2019
03/2018
03/2017
Cash From Operating Activities
-4.83 1,253.22 1,123.63 4,770.35 1,669.53 541.42
Cash From Investing Activities
647.25 0.62 0.79 965.77 -6.18 -4.28
Cash From Financing Activities
-642.99 -1,254.35 -1,124.29 -5,735.92 -1,666.19 -550.56
Capital Expenditures
13.92 4.27
Free Cash Flow
-1,202.52 -1,361.61 -1,238.12 -917.75 -1,183.66 -1,009.59
Change in Cash
-0.57 -0.51 0.13 0.19 -2.84 -13.42

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top